How professional networks help Qualified Persons navigate new challenges

Published: 19-Aug-2026 Featured companies: NSF
Manufacturing Regulatory Research & Development

The NSF QP Alumni community provides ongoing support, connecting Qualified Persons with peers, regulators and expertise throughout their careers and beyond formal training

How professional networks help Qualified Persons navigate new challenges

How can a professional network help Qualified Persons tackle real-world challenges? In this short testimonial, Gareth explains how the connections built through the NSF QP Alumni community continue to provide practical support throughout his QP career. From staying connected with peers and regulators to accessing expertise and finding support when new challenges arise, Gareth shares how the network has become a valuable professional resource beyond training itself. Learn more about NSF Qualified Person Training: https://www.nsf.org/training/series/pharmaceutical-qualified-person-training-overview

NSF QP Training: Support When You Need It Most | Gareth

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory
The foundations of pharmaceutical compliance every new professional needs

The foundations of pharmaceutical compliance every new professional needs

Read more
Discover the essential principles of pharmaceutical quality and compliance, and learn why building strong foundations early helps improve performance, support regulatory success and reduce risk

Trending Articles

  1. From concept to commercialisation: scientific partnership for topical & transepithelial drug development MedPharm partners with pharmaceutical and biotech companies to develop, de-risk and advance topical and transepithelial drug products through formulation development, testing and manufacturing
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    From PFAS to future restrictions: why manufacturers need proactive chemical control Rising chemical regulation is forcing industry to rethink risk management. Experts at EcoOnline recommend connecting safety data, workforce protection and supply-chain insight to stay compliant, resilient and operationally prepared
  3. Amgen announces new Science and Innovation Center in Hyderabad to bolster R&D The new hub will open next year and forms part of a growing community of pharma giants choosing Genome Valley as a base for their research facilities
  4. FDA escalates action against Dabur India over systemic data-integrity and cGMP failures The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies

Relevant companies

See more

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Regulatory
The foundations of pharmaceutical compliance every new professional needs

The foundations of pharmaceutical compliance every new professional needs

Discover the essential principles of pharmaceutical quality and compliance, and learn why building strong foundations early helps improve performance, support regulatory success and reduce risk
Regulatory
Why high-quality QP training is critical for patient safety and compliance

Why high-quality QP training is critical for patient safety and compliance

Discover why high-quality Qualified Person training goes beyond theory, combining expert mentoring, practical experience and rigorous preparation to support patient safety and regulatory excellence
Manufacturing
New legal duties for QPs in decentralised manufacturing

New legal duties for QPs in decentralised manufacturing

In this clip, Dr. Peter Gough explains that QPs will be responsible for supervising decentralised activities, conducting regular audits, carrying out periodic on-site visits, confirming GMP compliance to regulatory authorities and notifying changes that may affect quality or safety
Regulatory
Why FDA inspectors focus on senior management oversight and quality culture

Why FDA inspectors focus on senior management oversight and quality culture

Learn why executive oversight matters, how inspectors evaluate quality culture, and what organisations should do before an inspector arrives on site
Regulatory
FDA inspection readiness: How to prepare for surveillance and pre-approval inspections

FDA inspection readiness: How to prepare for surveillance and pre-approval inspections

Learn how to prepare for surveillance and pre-approval inspections, build a culture of continuous compliance and reduce regulatory risk
Regulatory
FDA inspection outcomes explained: Form 483, VAI, OAI, and effective regulatory responses

FDA inspection outcomes explained: Form 483, VAI, OAI, and effective regulatory responses

Learn what a Form FDA 483 means, how to develop an effective response within 15 business days, and how FDA evaluates inspection outcomes and regulatory risk
Regulatory
What’s changing at the FDA? Dr. Julia Marré explains the new U.S. regulatory landscape

What’s changing at the FDA? Dr. Julia Marré explains the new U.S. regulatory landscape

From shifting expectations around submissions to evolving agency–industry interactions, Dr. Marré breaks down what companies need to know to stay compliant, competitive, and prepared
Subscribe now